Restless Legs Syndrome, Periodic Leg Movements, and Periodic Limb Movement Disorder in Children

Pediatric Clinics of North America

Volumn 58, Issue 3, 2011, Pages 591-620

  Durmer, Jeffrey S ^a,b   Quraishi, Ghazala H ^a  

^a Fusion Sleep   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Children; Periodic leg movements; Periodic limb movement disorder; Restless legs syndrome

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; CLONIDINE; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; GABAPENTIN ENACARBIL; IRON; LEVODOPA; METHADONE; MORPHINE; OPIATE DERIVATIVE; OXYCODONE; PRAMIPEXOLE; ROPINIROLE; TEMAZEPAM; ZOLPIDEM;

ABSENCE OF SIDE EFFECTS; ATTENTION DEFICIT DISORDER; CHILD; DEPRESSION; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRUG TOLERABILITY; EDEMA; EMOTIONAL LIABILITY; FLUID RETENTION; GENETIC ANALYSIS; HUMAN; HYPERSOMNIA; HYPOTENSION; INSOMNIA; MENTAL DISEASE; MOTOR DYSFUNCTION; MUSCLE RELAXATION; NAUSEA; NOSE CONGESTION; PATHOPHYSIOLOGY; PERIODIC LIMB MOVEMENT DISORDER; PREVALENCE; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; REVIEW; SEDATION; SIDE EFFECT; SLEEP DEPRIVATION; SYMPTOMATOLOGY; VOMITING;

CHILD; HUMANS; LEG; MOVEMENT; POLYSOMNOGRAPHY; PREVALENCE; RESTLESS LEGS SYNDROME; UNITED STATES;

EID: 79956154256     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2011.03.005     Document Type: Review

References (163)

1. Ekbom K.A. Restless legs: a clinical study. Acta Med Scand Suppl 1945, 158:1-122.
2. Walters A.S., Picchietti D.L., Ehrenberg B.L., et al. Restless legs syndrome in childhood and adolescence. Pediatr Neurol 1994, 11(3):241-245.
3. Picchietti D.L., Walters A.S. Restless legs syndrome and periodic limb movement disorder in children and adolescents comorbidity with attention-deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 1996, 5:729-740.
4. Picchietti D.L., Stevens H.E. Early manifestations of restless legs syndrome in childhood and adolescence. Sleep Med 2008, 9(7):770-781.
5. Lavigne G.J., Montplaisir J.Y. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994, 17:739-743.
6. Berger K., Luedemann J., Trenkwalder C., et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004, 164:196-202.
7. Ulfberg J., Nystrom B., Carter N., et al. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001, 16:1159-1163.
8. Montplaisir J., Boucher S., Poirier G., et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997, 12(1):61-65.
9. Walters A.S., Hickey K., Maltzman J., et al. A questionnaire study of 138 patients with restless legs syndrome: the ''Night-Walkers'' survey. Neurology 1996, 46(1):92-95.
10. Walters A.S. The International Restless Legs Syndrome Study Group. Toward a better definition of the restless legs syndrome. Mov Disord 1995, 10:634-642.
11. Allen R.P., Picchietti D., Henning W.A., et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the RLS diagnosis and epidemiology workshop at the NIH. Sleep Med 2003, 4:101-119.
12. The International RLS Study Group Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003, 4:121-132.
13. Zucconi M., Ferini-Strambi L. Epidemiology and clinical findings of restless legs syndrome. Sleep Med 2004, 5:293-299.
14. Allen R.P., Walters A.S., Montplaisir J., et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Internal Med 2005, 156:1286-1292.
15. Juuti A.K., Laara E., Rajala U., et al. Prevalence and associated factors of restless legs in a 57-year-old urban population in northern Finland. Acta Neurol Scand 2009, 10:1111.
16. Henning W., Walters A.S., Allen R.P., et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms and treatment) primary care study. Sleep Med 2004, 5(3):237-246.
17. Picchietti D., Allen R.P., Walters A.S., et al. Restless legs syndrome: prevalence and impact in children and adolescents-the Peds REST study. Pediatrics 2007, 120(2):253-266.
18. Arbuckle R., Abetz L., Durmer J.S., et al. Development of the pediatric restless legs syndrome severity scale (P-RLS-SS): a patient-reported outcome measure of pediatric RLS symptoms and impact. Sleep Med 2010, 11:897-906.
19. Picchietti D.L., England S.J., Walters A.S., et al. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol 1998, 13(12):588-594.
20. Cortese S., Konofal E., Lecendreux M., et al. Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep 2005, 28(8):1007-1013.
21. American Academy of Sleep Medicine. International classification of sleep disorders. 2nd edition. Diagnostic and coding manual. Westchester (IL): AASM; 2005.
22. O'Brien L.M., Holbrook C.R., Jones F., et al. Ethnic difference in periodic limb movements in children. Sleep Med 2007, 8(3):240-246.
23. Stephansson H., Rye D.B., Hicks A., et al. A genetic risk factor for periodic limb movements in sleep. NEJM 2007, 357:639-647.
24. Gamaldo C.E., Earley C.J. Restless legs syndrome: a clinical update. Chest 2006, 130(5):1596-1604.
25. Benes H., Walters A.S., Allen R.P., et al. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Mov Disord 2007, 22(Suppl 18):S401-S408. [review. Erratum in Mov Disord 2008;23(8):1200].
26. Yang C., White D.P., Winkelman J.W. Antidepressants and periodic leg movements of sleep. Biol Psychiatry 2005, 58:510-514.
27. Hoque R., Chesson A.L. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med 2010, 6(1):79-83.
28. Shraf S.M., Tubman A., Smale P. Prevalence of concomitant sleep disorders in patients with obstructive sleep apnea. Sleep Breath 2005, 9:50-56.
29. Al-Alawi A., Mulgrew A., Tench E., et al. Prevalence, risk factors and impact on daytime sleepiness and hypertension of periodic leg movements with arousals in patients with obstructive sleep apnea. J Clin Sleep Med 2006, 2(3):281-287.
30. Baran A.S., Richert A.C., Douglass A.B., et al. Change in periodic limb movement index during treatment of obstructive sleep apnea with continuous positive airway pressure. Sleep 2003, 26(6):717-720.
31. Walters A.S., Lavigne G., Hening W., et al. The scoring of movements in sleep. J Clin Sleep Med 2007, 3(2):155-167.
32. Sforza E., Pichot V., Barthelemy J.C., et al. Cardiovascular variability during periodic leg movements: a spectral analysis approach. Clin Neurophysiol 2005, 116:1096-1104.
33. Walter A.S., Rye D.B. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease and stroke. Sleep 2009, 32(5):589-597.
34. Gosselin N., Lanfranchi P., Michaud M., et al. Age and gender effects on heart rate activation associated with periodic leg movements in patients with restless legs syndrome. Clin Neurophysiol 2003, 114:2188-2195.
35. Chervin R.D., Archbold K.H., Dillon J.E., et al. Associations between symptoms of inattention, hyperactivity, restless legs and periodic leg movements. Sleep 2002, 25(2):213-218.
36. Chervin R.D., Dillon J.E., Archbald K.H., et al. Conduct problems and symptoms of sleep disorders in children. J Am Acad Child Adolesc Psychiatry 2003, 42(2):201-208.
37. Pearson V.E., Allen R.P., Dean T., et al. Cognitive deficits associated with restless legs syndrome (RLS). Sleep Med 2006, 7:25-30.
38. Oner P., Dirik E.B., Taner Y., et al. Association between low serum ferritin and restless legs syndrome in patients with attention deficit hyperactivity disorder. Tohoku J Exp Med 2007, 213(3):269-276.
39. Silvestri R., Gagliano A., Arico I., et al. Sleep disorders in children with attention-deficit/hyperactivity disorder (ADHD) recorded overnight by video-polysomnography. Sleep Med 2009, 10(10):1132-1138.
40. Wagner M.L., Walters A.S., Fisher B.C. Symptoms of attention-deficit/hyperactivity disorder in adults with restless legs syndrome. Sleep 2004, 27(8):1499-1504.
41. Wiggs L., Montgomery P., Stores G. Actigraphic and parent reports of sleep patterns and sleep disorders in children with subtypes of attention-deficit hyperactivity disorder. Sleep 2005, 28(11):1437-1445.
42. Sevim S., Dogu O., Kaleagasi H., et al. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry 2004, 75(2):226-230.
43. Picchietti D., Winkelman J.W. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 2005, 28(7):891-898.
44. Winkelmann J., Prager M., Lieb R., et al. "Anxietas tibiarum" Depression and anxiety disorders in patients with restless legs syndrome. J Neurol 2005, 252(1):67-71.
45. Lee H.B., Hening W.A., Allen R.P., et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci 2008, 20(1):101-105.
46. Allen R.P., Walters A.S., Montplaisir J., et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005, 165(11):1286-1289.
47. Winkelman J.W., Redline S., Baldwin C.M., et al. Polysomnographic and health-related quality of life correlates of restless legs syndrome in the sleep heart health study. Sleep 2009, 32(6):772-778.
48. Happe S., Reese J.P., Stiasny-Kolster K., et al. Assessing health-related quality of life in patients with restless legs syndrome. Sleep Med 2009, 10(3):295-305.
49. Allen R.P., Burchell B.J., MacDonald B., et al. Validation of the self-completed Cambridge-Hopkins questionnaire (CH-RLSq) for ascertainment of restless legs syndrome (RLS) in a population survey. Sleep Med 2009, 10(10):1097-1100.
50. Rothdach A.J., Trenkwalder C., Haberstock J., et al. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 2000, 54(5):1064-1068.
51. Iber C., Ancoli-Israel A., Chesson A.I., et al. The AASM manual for the scoring of sleep and associated events; rules, terminology and technical specifications 2007, AASM, Westchester (IL). 1st edition.
52. Crabtree V.M., Ivanenko A., O'Brien L.M., et al. Periodic limb movement disorder of sleep in children. J Sleep Res 2003, 12:73-81.
53. Montgomery-Downs H.E., O'Brien L.M., Gulliver T.E., et al. Polysomnographic characteristics in normal preschool and early school-aged children. Pediatrics 2006, 117:741-753.
54. Pennestri M.H., Whittom S., Adam B., et al. PLMS and PLMW in healthy subjects as a function of age: prevalence and interval distribution. Sleep 2006, 29:1183-1187.
55. Traeger N., Schultz B., Pollock A.N., et al. Polysomnographic values in children 2-9 years old: additional data and review of the literature. Pediatr Pulmonol 2005, 40:22-30.
56. Picchietti D.L., Picchietti M.A. Pediatric restless legs syndrome and periodic limb movement disorder: parent-child pairs. Sleep Med 2009, 10:925-931.
57. Ferri R., Zucconi M., Manconi M., et al. New approaches to the study of periodic leg movements during sleep in restless legs syndrome. Sleep 2006, 29(6):759-769.
58. Ferri R., Manconi M., Lanuzza B., et al. Age-related changes in periodic leg movements during sleep in patients with restless legs syndrome. Sleep Med 2008, 9(7):790-798.
59. Ferri R., Franceschini C., Zucconi M., et al. Sleep polygraphic study of children and adolescents with narcolepsy/cataplexy. Dev Neuropsychol 2009, 34(5):523-538.
60. Bruni O, Ferri R, Verrillo E, et al. New approaches to the study of leg movements during sleep in ADHD children. In: Proceedings of the 20th meeting of the Associated Sleep Societies. Salt Lake City (UT), June 17-22, 2006. Sleep 2006;29(Suppl 2006). p. 259.
61. Trotti L.M., Bliwise D.L., Greer S.A., et al. Correlates of PLMs variability over multiple nights and impact upon RLS diagnosis. Sleep Med 2009, 10:668-671.
62. Sforza E., Johannes M., Bassetti C. The PAM-RL ambulatory device for detection of periodic leg movements: a validation study. Sleep Med 2005, 6:407-413.
63. Morrish E., King M.A., Pilsworth S.N., et al. Periodic limb movement in a community population detected by a new actigraphy technique. Sleep Med 2002, 3:489-495.
64. Rye D.B. Parkinson's disease and RLS: the dopaminergic bridge. Sleep Med 2004, 5:317-328.
65. Clemens S., Rye D., Hochman S. RLS revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 2006, 67:125-130.
66. Nordlander N.B. Restless legs. Br J Phys Med 1954, 17:160-162.
67. Earley C.J., Connor J.R., Beard J.L., et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000, 54:1698-1700.
68. Mizuno S., Mihara T., Miyaoka T., et al. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 2005, 14:43-47.
69. Earley C.J., Barker P.B., Horska A., et al. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med 2006, 7:459-461.
70. Allen R.P., Barker P.B., Wehrl F., et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001, 56:263-265.
71. Schmidauer C., Sojer M., Seppi K., et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 2005, 58:630-634.
72. Connor J.R., Boyer P.J., Menzies S.L., et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003, 61:304-309.
73. Connor J.R., Wang X.S., Patton S.M., et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology 2004, 62:1563-1567.
74. Erikson K.M., Jones B.C., Beard J.L. Iron deficiency alters dopamine transporter functioning in rat striatum. J Nutr 2000, 130:2831-2837.
75. Erikson K.M., Jones B.C., Hess E.J., et al. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol Biochem Behav 2001, 69:409-418.
76. Wang X., Wiesinger J., Beard J., et al. Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome. J Neurol Sci 2004, 220:59-66.
77. Early C.J., Ponnuru P., Wang X., et al. Altered iron metabolism in lymphocytes from subjects with restless legs syndrome. Sleep 2008, 31(6):847-852.
78. Desai A.V., Cherkas L.F., Spector T.D., et al. Genetic influences in self-reported symptoms of obstructive sleep apnoea and restless legs: a twin study. Twin Res 2004, 7(6):589-595.
79. Winkelmann J., Muller-Myhsok B., Wittchen H.U., et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 2002, 52(53):297-302.
80. Mathias R.A., Hening W., Washburn M., et al. Segregation analysis of restless legs syndrome: possible evidence for a major gene in a family study using blinded diagnoses. Hum Hered 2006, 62(3):157-164.
81. Lazzarini A., Walters A.S., Hickey K., et al. Studies of penetrance and anticipation in five autosomal-dominant restless legs syndrome pedigrees. Mov Disord 1999, 14:111-116.
82. Trenkwalder C., Seidel V.C., Gasser T., et al. Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome. Mov Disord 1996, 11:389-394.
83. Vogl F.D., Pichler I., Adel S., et al. Restless legs syndrome: epidemiological and clinicogenetic study in a South Tyrolean population isolate. Mov Disord 2006, 21:1189-1195.
84. Konieczny M., Bauer P., Tomiuk J., et al. CAG repeats in Restless Legs syndrome. Am J Med Genet B Neuropsychiatr Genet 2006, 141:173-176.
85. Desautels A., Turecki G., Montplaisir J., et al. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet 2001, 69:1266-1270.
86. Desautels A., Turecki G., Montplaisir J., et al. Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity. Arch Neurol 2005, 62:591-596.
87. Bonati M.T., Ferini-Strambi L., Aridon P., et al. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 2003, 126:1485-1492.
88. Chen S., Ondo W.G., Rao S., et al. Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet 2004, 74:876-885.
89. Winkelmann J., Lichtner P., Putz B., et al. Evidence for further genetic locus heterogeneity and confirmation of RLS-1 in restless legs syndrome. Mov Disord 2006, 21:28-33.
90. Pichler I., Marroni F., Volpato C.B., et al. Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate. Am J Hum Genet 2006, 79:716-723.
91. Levchenko A., Provost S., Montplaisir J.Y., et al. A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13. Neurology 2006, 67:900-901.
92. Winkelmann J., Schormair B., Lichtner P., et al. Genomewide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007, 39:1000-1006.
93. Muhle H., Neumann A., Lohmann-Hedrich K., et al. Childhood-onset restless legs syndrome: clinical and genetic features of 22 families. Mov Disord 2008, 23(8):1113-1121.
94. Young J.E., Vilariño-Güell C., Lin S.C., et al. Clinical and genetic description of a family with a high prevalence of autosomal dominant restless legs syndrome. Mayo Clin Proc 2009, 84(2):134-138.
95. Picchietti D.L., Arbuckle R., Abetz L., et al. Pediatric restless legs syndrome: analysis of symptom descriptions and drawings. J Child Neurol Proc 2011, 26. in press.
96. Mohri I., Kato-Nishimura K., Tachibana N., et al. RLS: an unrecognized cause for bedtime problems and insomnia in children. Sleep Med 2008, 9:701-702.
97. Rajaram A., Walters A.S., England S.J., et al. Some children with growing pains may actually have restless legs syndrome. Sleep 2004, 27(4):767-773.
98. Evans A.M., Scutter S.D. Prevalence of growing pains in young children. J Pediatr 2004, 145:255-258.
99. Kryger M.H., Otake K., Foerster J. Low body stores of iron and restless legs syndrome: a correctable cause of insomnia in adolescents and teenagers. Sleep Med 2002, 3:127-132.
100. Martin B.T., Williamson B.D., Edwards N., et al. Parental symptom report and periodic limb movements of sleep in children. J Clin Sleep Med 2008, 4(1):57-61.
101. Chervin R.D., Hedger K.M. Clinical prediction of periodic leg movements during sleep in children. Sleep Med 2001, 2:501-510.
102. Silvestri R., Gagliano A., Arico I., et al. Sleep disorders in children with ADHD recorded overnight by video-polysomnography. Sleep Med 2009, 10:1132-1138.
103. Konofal E., Lecendreux M., Cortese S. Sleep and ADHD. Sleep Med 2010, 11:652-658.
104. Decker M.J., Hue G.E., Caudle W.M., et al. Episodic neonatal hypoxia evokes executive dysfunction and regionally specific alterations in markers of dopamine signaling. Neuroscience 2003, 117:417-425.
105. Decker M.J., Jones K.A., Solomon I.G., et al. Reduced extracellular dopamine and increased responsiveness to novelty: neurochemical and behavioral sequelae of intermittent hypoxia. Sleep 2005, 28(2):169-178.
106. Faraone S.V., Doyle A.E., Mick E., et al. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 2001, 158(7):1052-1057.
107. Li D., Sham P.C., Owen M.J., et al. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 2006, 15(14):2276-2284.
108. Lowe N., Kirley A., Hawi Z., et al. Joint analysis of the DRD5 marker concludes association with attention deficit/hyperactivity disorder confined to the predominately inattentive and combined subtypes. Am J Hum Genet 2004, 74(2):348-356.
109. Misener V.L., Luca P., Azeke O., et al. Linkage of the dopamine receptor D1 gene to attention deficit/hyperactivity disorder. Mol Psychiatry 2004, 9(5):500-509.
110. VanNess S.H., Owens M.J., Kilts C.D. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet 2005, 6:55.
111. Cook E.H., Stein M.A., Krasowski M.D., et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995, 56:993-998.
112. LaHoste G.J., Swanson J.M., Wigal S.B., et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996, 1:21-124.
113. Coghill D., Banaschewski T. The genetics of ADHD. Expert Rev Neurother 2009, 9(10):1547-1565.
114. Konofal E., Lecendreux M., Arnulf I., et al. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 2004, 158:1113-1115.
115. Konofal E., Cortese S., Marcahnd M., et al. Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children. Sleep Med 2007, 8:711-715.
116. Konofal E., Lecendreux M., Deron J., et al. Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol 2008, 38:20-26.
117. Frauscher B., Gschliesser V., Brandauer E., et al. The severity of RLS and augmentation in a prospective patient cohort: association with ferritin levels. Sleep Med 2009, 10(6):611-615.
118. Whittom S., Dauvilliers Y., Pennestri M.H., et al. Age-at-onset in restless legs syndrome: a clinical and polysomnographic study. Sleep Med 2007, 9(1):54-59.
119. Earley C.J. Restless legs syndrome. N Engl J Med 2003, 348(21):2103-2109.
120. Sun E.R., Chen C.A., Ho G., et al. Iron and the restless legs syndrome. Sleep 1998, 21:371-377.
121. O'Keeffe S.T., Gavin K., Lavan J.N. Iron status and restless legs syndrome in the elderly. Age Ageing 1994, 23(3):200-203.
122. Simakajornboon N., Gozal D., Vlasic V., et al. PLMS and iron status in children. Sleep 2006, 26(6):735-738.
123. Davis B.J., Rajput A., Rajput M.L., et al. A randomized double-blind placebo controlled trail of iron in restless legs syndrome. Eur Neurol 2000, 43:70-75.
124. Early C.J., Heckler D., Allen R.P. Repeated IV doses of iron provide effective supplemental treatment of restless legs syndrome. Sleep Med 2005, 6:301-305.
125. Ondo W.G. IV iron dextran for severe refractory RLS. Sleep Med 2010, 11:494-496.
126. Grote L., Leissner L., Hedner J., et al. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. Mov Disord 2009, 24(10):1445-1452.
127. Walters A.S., Mandelbaum D.E., Lewin D.S., et al. Dopaminergic Study Group. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Pediatr Neurol 2000, 22:182-186.
128. Konofal E., Arnulf I., Lecendreux M., et al. Ropinirole in a child with ADHD and RLS. Pediatr Neurol 2005, 32:350-351.
129. Kotagal S., Silber M.H. Childhood-onset restless legs syndrome. Ann Neurol 2004, 56(6):803-807.
130. Starn A.L., Udall J.N. Iron deficiency anemia, pica, and restless legs syndrome in a teenage girl. Clin Pediatr (Phila) 2008, 47(1):83-85.
131. Cortese S., Konofal E., Lecendreux M. Effectiveness of ropinirole for RLS and depressive symptoms in an 11-year-old girl. Sleep Med 2009, 10(2):259-261.
132. Picchietti D.L., Walters A.S. Moderate to severe periodic limb movement disorder in childhood and adolescence. Sleep 1999, 22(3):297-300.
133. Guilleminault C., Palombini L., Pelayo R., et al. Sleepwalking and sleep terrors in prepubertal children: what triggers them?. Pediatrics 2003, 111(1):e17-e25.
134. Martinez S., Guilleminault C. Periodic leg movements in prepubertal children with sleep disturbance. Dev Med Child Neurol 2004, 46(11):765-770.
135. Conti C.F., de Oliveira M.M., Andriolo R.B., et al. Levodopa for idiopathic restless legs syndrome: evidence-based review. Mov Disord 2007, 22(13):1943-1951.
136. Allen R.P., Earley C.J. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996, 19:205-213.
137. Garcia-Borreguero D., Williams A. Dopamine augmentation of restless legs syndrome. Sleep Med Rev 2010, 14:339-346.
138. Paulus W., Trenkwalder C. Less is more: pathophysiology of dopaminergic related augmentation in restless legs syndrome. Lancet Neurol 2006, 5:878-886.
139. Newcorn J.H., Schulz K., Harrison M., et al. Alpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in children. Pediatr Clin North Am 1998, 45(5):1022-1099. [viii].
140. Prince J.B., Wilens T.E., Biederman J., et al. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry 1996, 35(5):599-605.
141. Wager M.L., Walters A.S., Coleman R.G., et al. Randomized double-blind placebo-controlled study of clonidine in restless legs syndrome. Sleep 1996, 19(1):52-58.
142. Owens J.A., Rosen C.L., Mindell J.A. Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians. Pediatrics 2003, 111(5 Pt 1):e628-e635.
143. Walters A.S., Wagner M.L., Hening W.A., et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993, 16:327-332.
144. Kaplan P.W., Allen R.P., Buchholz D.W., et al. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep 1993, 16(8):717-723.
145. Ross D.A., Narus M.S., Nutt J.G. Control of medically refractory RLS with intrathecal morphine: case report. Neurosurgery 2008, 62(1):e263.
146. Jakobsson B., Ruuth K. Successful treatment of RLS with an implanted pump for intrathecal drug delivery. Acta Anaesthesiol Scand 2002, 46:114-117.
147. Ondo W.G. Methadone for refractory RLS. Mov Disord 2005, 20(3):345-348.
148. Walters A.S. Review of receptor agonist and antagonist studies relevant to the opiate system in restless legs syndrome. Sleep Med 2002, 3:301-330.
149. Laurma H., Markkula J. Treatment of restless legs syndrome with tramadol: an open study. J Clin Psychiatry 1999, 60:241-244.
150. Garcia-Borreguero D., Larrosa O., de la Llave Y., et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002, 59(10):1573-1579.
151. Happe S., Klosch G., Saletu B., et al. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin. Neurology 2001, 57(9):1717-1719.
152. Happe S., Sauter C., Klosch G., et al. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology 2003, 48(2):82-86.
153. Cundy K.C., Sastry S., Luo W., et al. Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin. J Clin Pharmacol 2008, 48(12):1378-1388.
154. Kushida C.A., Becker P.M., Ellenbogan A.L., et al. XP052 Study Group. A randomized, double-blind, placebo-controlled trial of XP13512/GSK1838262 in patients with RLS. Neurology 2009, 72(5):439-446.
155. Bogan R., Bornemann M.A., Kushida C.A., XP060 Study Group, et al. Long-term maintenance treatment of RLS with gabapentin enacarbil: a randomized control study. Mayo Clin Proc 2010, 85(7):693-694.
156. Matthews W.B. Treatment of restless legs syndrome with clonazepam. Br Med J 1979, 1:751.
157. Oshtory M.A., Vijayan N. Clonazepam treatment of insomnia due to sleep myoclonus. Arch Neurol 1980, 37:119-120.
158. Saletu M., Ander P., Saletu-Zyhlarz G., et al. RLS and PLMD acute placebo-controlled sleep laboratory studies with clonazepam. Eur Neuropsychopharmacol 2001, 11:153-161.
159. Silber M.H., Ehrenberg B.L., Allen R.P., et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 2004, 79(7):916-922.
160. Hening W., Allen R., Earley C., et al. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine review. Sleep 1999, 22(7):970-999.
161. Kim S.W., Shin I.S., Kim J.M., et al. Bupropion may improve restless legs syndrome. A report of three cases. Clin Neuropharmacol 2005, 28:298-301.
162. Lee J.J., Erdos J., Wilkosz M.F., et al. Bupropion as a possible treatment option for restless legs syndrome. Ann Pharmacother 2009, 43:370-374.
163. Nofzinger E.A., Fasiczka A., Berman S., et al. Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. J Clin Psychiatry 2000, 61:858-862.